RETRACTION PHYSIOLOGY.
For the article ''New findings of the correlation between acupoints and corresponding brain cortices using functional MRI,'' by Z. H. Cho, S. C. Chung, J. P. Jones, J. B. Park, H. J. Park, H. J. Lee, E. K. Wong, and B. I. Min, which appeared in issue 5, March 3, 1998, of Proc. Natl. Acad. Sci. USA (95, (2670) (2671) (2672) (2673) , the authors reported a specific cortical correlation with a given acupoint and suggested that there could be correlation between acupoint stimulation and cortical activation, for example via increased blood flow in the visual cortex. Accumulating evidence suggests that the central nervous system is essential for processing these effects, via its modulation of the autonomic nervous system, neuro-immune system, and hormonal regulation. We, therefore, carried out a series of studies questioning whether there really is point specificity in acupuncture, especially vis-à-vis pain and acupuncture analgesic effects as we originally reported in our PNAS article, that had not yet been confirmed by other studies. We have reported some of these results as preliminary observations (1, 2) . Having concluded that there is no point specificity, at least for pain and analgesic effects, and that we no longer agree with the results in our PNAS article, the undersigned authors are retracting the article. J. P. Jones, J. B. Park, and H. J. Park have not approved this retraction. albumin ͉ IgG ͉ MHC class I ͉ hypoalbuminemia ͉ hypogammaglobulinemia T he neonatal Fc receptor, FcRn, is a heterodimer of a nonclassical MHC class I (MHC I) ␣-chain and ␤ 2 -microglobulin (␤ 2 m) that binds the two most abundant serum proteins, IgG (1) and albumin (2), after their constitutive uptake by many cells of the body. FcRn binds both ligands with high affinity at the low pH of acid endosomes and releases them at the physiologic pH of the cell surface, where they are free to circulate, thus diverting them from lysosomal degradation (2) (3) (4) (5) . Such FcRn-mediated recycling explains the uniquely long halflives and the direct concentration-catabolism effect of IgG and albumin. The capacity of this salvage mechanism is astonishing; without FcRn, mice would need dramatically increased albumin and IgG synthetic rates to maintain normal concentrations of these proteins (6) .
In accordance with this hypothesis, we have found that mice lacking FcRn because of defective genes for the ␣-chain or ␤ 2 m show low serum concentrations and rapid degradation rates of both IgG and albumin (2) . Searching for analogous FcRndeficient humans, we reexamined two siblings, born of a consanguineous marriage, whose disorder, familial hypercatabolic hypoproteinemia (FHH), had been thoroughly studied in the late 1960s (8, ‫.)ءء‬ Both siblings manifested hypercatabolic albumin and IgG deficiencies for which no known cause could be found at the time of investigation. Recognizing that these two individuals might have been homozygous for a defect in one or the other of the two genes encoding the heterodimeric FcRn, we analyzed their archived sera, the subjects themselves being no longer available. We now ascribe their defect to a severe FcRn deficiency resulting from a ␤ 2 m gene mutation.
Results
Analyzing serum samples by ELISA, we found soluble ␤ 2 m (s␤ 2 m) concentrations for the two siblings, S1 and S2, to be Ͻ10 ng͞ml ( Table 1) . These values were Ϸ100-fold less than those for our three control groups, which included three normal sera (N1, N2, and N3) analyzed simultaneously, eight National Institutes of Health (NIH)-archived sera analyzed simultaneously, and assay normal values. The serum concentrations of soluble HLA (sHLA) were likewise very low, being Ͻ0.2% of the normal mean (Table 1) . Values for serum iron, total iron-binding capacity (TIBC), percent transferrin saturation with iron (%TS), and ferritin, determined either in our laboratories or at NIH in the 1960s, were normal (Table 1) .
We PCR-amplified and sequenced all exons of both the ␤ 2 m and the FcRn ␣-chain genes from DNA purified from sera of the two siblings and three normal individuals. Whereas gene sequences in both directions of ␤ 2 m exons 2, 3, and 4 of all individuals were normal, the sequences of exon 1 of ␤ 2 m in the two siblings alone showed a single nucleotide transversion (G913C) (Fig. 1a) . This mutation was confirmed by digesting the amplified exon 1 DNA with a restriction enzyme that uniquely distinguishes between the normal and the mutant nucleotide at this site (Fig. 1c) . The pattern of bands of digested DNA from the two siblings was distinctly different from those of the normal individuals (Fig. 1b) . The G913C transversion would be predicted to cause a mutation from alanine to proline at amino acid 11 at the midpoint of the signal sequence (Fig. 1d) . We estimated the frequency of this G913C mutation in an ancestry-matched population by assessing a collection of 100 DNA samples with the restriction enzyme digestion assay described in Fig. 1c and found no other instances of such a mutation. Therefore, the gene frequency of this mutation in the sampled population is Ͻ0.5%. The sequences of the gene for the FcRn ␣-chain in the two siblings were normal.
To test the prediction that the mutant ␤ 2 m signal sequence would hinder cellular expression of ␤ 2 m protein, we transfected a ␤ 2 m-lacking human cell line with a plasmid containing mutant Anticipating that ␤ 2 m expression would rescue the surface expression of MHC I in this ␤ 2 m-deficient cell line, we also Sera from the two siblings, S1 and S2, along with three normal human sera and eight sera archived at NIH since the 1960s, were tested for s␤ 2m, sHLA, serum iron, TIBC, %TS, and ferritin, and they were compared with laboratory standard values for each assay, given as either normal range or mean Ϯ SD. The s␤ 2m and sHLA values for S1 and S2 are the means of two determinations, with deviations from the mean being Ͻ10%. S2 values have been corrected as described in Materials and Methods. ND, not determined. *Values extracted from NIH medical records from the 1960s. Fig. 2 b and d) . Cells transfected with wt ␤ 2 m cDNA showed high levels of MHC I expression (MFI ϭ 3,176); those transfected with empty vector (MFI ϭ 156) showed no expression beyond background levels; and those transfected with mut ␤ 2 m cDNA (MFI ϭ 738) showed levels of expression Ͻ20% of that seen in the wt (duplicate experiments, 19% and 13%). Equivalent results were seen when only those cells brighter than vector-transfected cells were analyzed; i.e., mut ␤ 2 m-transfected cells were 20% as bright as wt ␤ 2 mtransfected cells.
To measure total cellular, rather than simply surface, expression of mut ␤ 2 m, we subjected these same transfected cell preparations to an alternative analysis, namely, immunoblotting of detergent lysates of cells. Analyzing cell lysates directly, we found virtually no mut ␤ 2 m expression, whereas cells transfected with wt ␤ 2 m expressed considerable protein (Fig. 3a, lanes 2 and  3) . First immunoadsorbing with anti-␤ 2 m mAb, and then analyzing the immunoadsorbates by immunoblotting with anti-␤ 2 m polyclonal antibody, we found mutant ␤ 2 m expression to be evident but minimal (Ͻ10% of wt ␤ 2 m) (Fig. 3b, lanes 2 and 3) .
We also measured the capacity of mutant ␤ 2 m to enhance the expression of the FcRn heterodimer. Assessing cell lysates by immunoblot with anti-FcRn ␣-chain antibody, we noted that very little FcRn ␣-chain was expressed, even after transfection with wt ␤ 2 m (Fig. 3a, lane 2) . We therefore transfected the cells with FcRn ␣-chain cDNA and noted ␣-chain protein expression (Fig. 3a, lane 4) in the absence of ␤ 2 m, as others have reported (9) . Cotransfecting these cells with ␤ 2 m cDNA, we noted that mut ␤ 2 m was only 22% as effective as wt ␤ 2 m in enhancing the amount of FcRn ␣-chain seen in immunoblots (average of two experiments, 14% and 30%) (Fig. 3a, lanes 5 and 6 vs. 4) . Determination of whether diminished expression of mut ␤ 2 m protein resulted from defective transcription or translation was beyond the scope of the present study.
Discussion
Our analysis of the archived serum from these two consanguineous siblings with FHH indicated that both were homozygous for a single nucleotide transversion of the ␤ 2 m gene that encoded a mutation from an evolutionarily conserved alanine to a proline in the center of the hydrophobic core of the ␤ 2 m signal sequence ␣-helix. A proline at this site would be expected to disrupt targeting of the nascent polypeptide to the endoplasmic reticulum (10) . Indeed, the serum ␤ 2 m concentrations in the FHH siblings were very low, and the mutant ␤ 2 m cDNA was able to support only 10-20% of wt ␤ 2 m expression in a cell transfection assay.
It is clear that a proline mutant might compromise signal peptide function, depending on where it is situated in the sequence. The mutation of alanine to proline does not affect the net charge or hydrophobicity of the ␣-helix but presumably disturbs the secondary structure as a result of its helix-breaking properties, thus leading to compromised interaction with the signal recognition protein and abnormal insertion into the endoplasmic reticulum membrane (11) . Similar proline mutations in signal sequences have been described in specific diseases (12) (13) (14) (15) .
Although no ␤ 2 m gene mutations abrogating protein expression have been described in humans, some cancer cell lines bear null ␤ 2 m genes (16) . Most of these mutations have been cytoplasmic tail (CT) deletions in the leader sequence that result in reading frame shifts and downstream nonsense mutations. The only known substitution mutation is in the Daudi B cell line, where methionine is replaced by isoleucine as the N-terminal amino acid, abolishing ␤ 2 m expression. ␤ 2 m is generally known to be required for efficient expression and function of several classical and nonclassical members of the MHC I family of proteins, which are heterodimers consisting of ␤ 2 m and a distinguishing ␣-chain of about 43 kDa. The family members include FcRn, CD1, hemochromatosis protein (HFE), and MHC I itself. Considering the data available on the two siblings studied, we can conclude with virtual certainty that they were FcRn-deficient. Their phenotype, which features low serum IgG and albumin concentrations and hypercatabolism of both proteins, is mirrored by the ␤ 2 m and FcRn ␣-chain knockout mouse strains (2) . Unfortunately, we have no means of assessing FcRn expression directly in these siblings because we have available neither tissue nor a satisfactory assay of serum-soluble FcRn. However, the mutant ␤ 2 m cDNA, transfected into ␤ 2 mdeficient cells, was severely deficient in supporting the expression of FcRn. Moreover, sHLA concentrations in serum were very low in both siblings, and in a cell transfection assay, mut ␤ 2 m cDNA was able to rescue only Ϸ20% of normal surface expression of MHC I protein. Thus, these siblings were likely severely MHC I-deficient. Although they were probably also HFEdeficient, they showed no increase in saturation of transferrin with iron, perhaps because of their relative youth (34 and 17 years of age) or the low penetrance of the type 1 hemochromatosis genotype.
Concluding that the two FHH siblings were homozygous for a defective ␤ 2 m allele, we then reassessed the remainder of the pedigree for whom serum IgG concentrations were available (table 1 in ref. 8) . On the basis of the ␤ 2 m genotype of the two siblings, we inferred that six of eight of the studied relatives were definitely heterozygous, and two were likely heterozygous, for the ␤ 2 m gene (patients 5 and 6, the unaffected brother and sister of S1 and S2, had a 66% chance of being heterozygous). We noted that the IgG concentrations of these eight relatives (mean Ϯ SD ϭ 9.2 Ϯ 1.4 mg͞ml; P Ͻ 0.001) were distinctly lower than the normal value of 12.4 Ϯ 2.2 mg͞ml. Although we know nothing about the albumin concentrations in the eight relatives, the IgA, IgM, IgD, and -chain concentrations were not different from normal. A single normal ␤ 2 m allele thus may confer a moderate IgG deficiency. It is unclear whether mice expressing a single ␤ 2 m allele are IgG-deficient, although the one large published study of heterozygous ␤ 2 m knockout mice concluded that there were no gross differences in IgG concentrations between wt and heterozygotes (17) . Nevertheless, ␤ 2 m heterozygote mice expressed reduced levels of splenocyte MHC I and had diminished numbers of CD8-expressing thymocytes (18) .
On the basis of our analysis of 35-year-old archived sera, we conclude that FcRn deficiency caused by a mutant ␤ 2 m gene underlies the hypercatabolism of both IgG and albumin seen in FHH.
Materials and Methods
Cell Line. The ␤ 2 m-lacking human melanoma cell line FO-1 (19) , kindly provided by William Carson (Ohio State University, Columbus) was maintained in RPMI 1640 medium (Invitrogen) supplemented with 10% heat-inactivated FCS in a 5% CO 2 -humidified atmosphere at 37°C. Serum Samples. Sera from S1 and S2 and from eight anonymous NIH patients had been archived in NIH freezers since the late 1960s. Neither the patients nor tissue were available. The S2 serum used for protein determinations was found to have been concentrated 1.6-fold (calculated by measurement of electrolytes), likely because of sublimation in storage. The results given in Table 1 have, therefore, been corrected by dividing the observed values by 1.6. Additional sera were collected from three healthy adult individuals.
␤2m Serum Concentrations. The ␤ 2 m concentrations of the serum samples were determined by using a sandwich ELISA (␤ 2 m ELISA Kit; Alpha Diagnostic, San Antonio, TX). Briefly, 100 l of diluted serum of the normal individuals (1:100 dilution) and the two FHH patients (1:5 dilution) were loaded in duplicate wells in a 96-well plate coated with anti-human ␤ 2 m (h␤ 2 m) monoclonal antibody and incubated at room temperature for 30 min. The wells were washed five times with wash buffer, and 100 l of horseradish peroxidase-conjugated rabbit polyclonal antih␤ 2 m antibody was added into each well. The plate was further incubated at room temperature for 30 min. After five washes with wash buffer, 200 l of substrate solution mix was added into the wells. The reaction was stopped by adding 50 l of stop solution (0.5 M sulfuric acid), and the yellow color developed was read within 30 min at 450 nm by using an EL X 808 ELISA plate reader (Biotek Instruments, Luton, U.K.). A reference ␤ 2 m standard ranging from 1.25 to 50 ng͞ml was run in parallel with each experiment. Normal values for this assay, according to the supplier, are given in Table 1 .
Measurement of Iron, Ferritin, and Transferrin. Serum iron and TIBC were measured in the clinical laboratory of the Columbus Children's Hospital by using the pyridyl azo dye ascorbic acid method for iron, a competitive immunoassay for ferritin, and the alumina adsorption method for TIBC. %TS was calculated as 100 ϫ serum iron concentration͞TIBC. Normal values in Table  1 are from the same laboratory. Values at the time of the FHH siblings' NIH evaluation were taken from the hospital record. ELISA for sHLA. ELISA for sHLA was performed as described (20) . Briefly, mAb TP25-99 (a kind gift from SangStat Medical Corporation, Menlo Park, CA), which recognizes both ␤ 2 m-free and associated HLA (21) , was used as the capture antibody; rabbit anti-human ␤ 2 m (Accurate Chemical & Scientific, Westbury, NY) and horseradish peroxidase-coupled goat anti-rabbit IgG (Sigma) were used as the detection antibodies. A standard curve was generated with purified HLA-B7 diluted serially to concentrations between 20 and 0.3125 ng͞ml. Tetramethylbenzidine microplate substrate and stop solution (Kirkegaard & Perry Laboratories) were used. The plates were read at 450 nm by using the Bio-Tek ELx800 reader, and data were analyzed with KC3 software (Biotek Instruments). Values for sera of 27 normal individuals and the 8 archived NIH sera are given in Table 1 .
Serum DNA Extraction, PCR Amplification, and Mutational Analysis.
DNA was extracted from 400 l of serum by adsorption to silica-gel membrane (QIAamp DNA Blood Mini Kit; Qiagen, Valencia, CA) and quantified with the PicoGreen dsDNA quantitation method by fluorometry (Molecular Probes). PCR was performed in 50-l reactions containing 2.5 units of TaqDNA polymerase (Qiagen), 1ϫ buffer and solution Q, 2 mM MgCl 2 , 0.4 m dNTP mix, 200 nM of each primer, and 25 ng of serum DNA as template. Samples were subjected to PCR conditions as follows: initial denaturation at 95°C for 4 min, followed by 35 cycles of 94°C for 1 min, annealing at 57°C for 1 min, extension at 72°C for 1 min, and a final extension cycle at 72°C for 10 min. A positive cellular DNA and a negative template-free control were also run in parallel with each PCR run. After amplification, the DNA was resolved by electrophoresis through 1.5% agarose gels containing 0.5 g͞ml ethidium bromide, and was visualized on a UV transilluminator and compared with molecular weight markers run in parallel. Single specific bands observed in all PCRs were excised from the agarose gel and purified on QiaexII gel extraction beads (Qiagen), eluted in water, and sequenced with a 3730 DNA Analyzer (Applied Biosystems). All exonic fragments were amplified individually and sequenced one at a time. Primer pairs were chosen from the sequence at least 100 bp upstream of the exon start and at least 130 bp downstream from the end of exon, to ensure analysis of the junctions. Although normal, the sequences of S2 and one normal control individual (N3) contained a single copy of a known allotypic polymorphism, a synonymous C2585T (22) change encoding arginine-171 like the normal allele (23) (GenBank accession no. AF200219; data not shown).
Plasmids and Site-Directed Mutagenesis of h␤2m cDNA. We used expression vectors pCMV-Sport 6 (cDNA clone MGC:45276; Open Biosystems, Huntsville, AL) containing full-length h␤ 2 m cDNA (24) (GenBank accession no. BC032589), and pREP9 (Invitrogen) containing full-length human FcRn ␣-chain cDNA (23) (GenBank accession no. U12255). FHH mutant cDNA was prepared by site-directed mutagenesis (Quik Change Kit; Stratagene), with pCMV-Sport6 ␤ 2 m cDNA as the template. The upper oligonucleotide, 5Ј-GCCTTAGCTGTGCTCCCGC-TACTCTCTCTTTCTGG-3Ј, and the lower oligonucleotide, 5Ј-CCAGA A AGAGAGAGTAGCGGGAGCACAGCTA-AGGCC-3Ј, were used for mutation of alanine-11 to proline in the exon 1 signal sequence of the ␤ 2 m cDNA (base substitutions italicized). The generated mutant FHH cDNA was sequenced in both directions to ensure fidelity.
Cell Transfection. FO-1 cells were transfected with pCMVSport6 containing full-length human ␤ 2 m cDNA, FHH mutant ␤ 2 m cDNA, and pREP9 (Invitrogen) containing full-length FcRn ␣-chain cDNA by using Lipofectamine 2000 (Invitrogen) in accordance with instructions from the supplier. Brief ly, cells were plated on 10-cm dishes (Corning) overnight in antibioticfree medium. The next day, 90% conf luent cells were washed twice with serum-free medium and overlayed with 3 ml of serum-free and antibiotic-free medium containing 20 g of each plasmid and 60 l Lipofectamine, and then with 7 additional ml of medium. After 5 h of culture at 37°C, an additional 10 ml of antibiotic-free medium containing 20% FCS (10% final) was added. Cells were harvested at 24 h after transfection.
Flow Cytometry. Cells were detached from the 10-cm dishes by adding 1 ml of cell dissociation solution (Sigma), and were centrifuged at 400 ϫ g for 5 min at 4°C. Cells (1 ϫ 10 6 ) were incubated for 1 h at 4°C with 5 g͞ml of primary antibodies, mAb W6͞32 for MHC I expression, or BBM.1 for ␤ 2 m expression (in 200 l of PBS containing 0.2% BSA and 0.1% sodium azide). Cells were washed twice and incubated for 1 h with FITC-tagged goat anti-mouse IgG (Caltag, South San Francisco, CA). Cells were then washed three times and resuspended in 0. Immunoblotting. To detect FcRn and ␤ 2 m protein, transfected cells were collected and lysed in 0.15 M phosphate buffer, pH 6.0, containing 60 mM n-octyl ␤-D glucopyranoside (OG), 10 mM gluconic acid lactone, 1 mM EDTA, and a mixture of protease inhibitors (OG buffer), as described in ref. 25 . Equal amounts of total protein, as determined by bicinchoninic acid assay (Pierce), from all transfections were electrophoresed on a 12% polyacrylamide gel in SDS. Proteins were transferred onto a nitrocellulose membrane by wet-blotting at 150 mA for 2 h. Membranes were blocked with 5% milk in Tris buffered saline͞0.05% Tween 20 (TBST) for 1 h, followed by incubation with affinity-purified rabbit polyclonal antibody directed against the CT of the ␣-chain of human FcRn derived from immunizations with a GST fusion protein of CT [anti-CT(GST)] (1:1,000), or with rabbit polyclonal anti-␤ 2 m antibody (FL-119, 1:1,000 Santa Cruz Biotechnology) at 4°C overnight. After three washes with TBST, the membranes were incubated with secondary horseradish peroxidase-labeled donkey anti-rabbit IgG (1:5,000). Proteins were visualized by enhanced chemiluminescence and were quantified by densitometry with a Fluor-S-Max multiimager using QUAN-TITY ONE software (Bio-Rad) [except that Hyperfilm (Amersham Biosciences) was used for ␤-actin].
Immunoadsorption. Cells expressing human ␤ 2 m wt cDNA or FHH mutant cDNA were lysed as described above for immunoblotting. Equal amounts of total protein cell lysate were immunoadsorbed with 1 g͞ml BBM.1 and Protein-A agarose (Invitrogen) overnight at 4°C, as described (7) . The agarose complexes were washed five times with the OG buffer, and the bound proteins were eluted in SDS sample buffer containing 2-mercaptoethanol by boiling for 10 min. Eluted proteins were separated on a 14% polyacrylamide gel in SDS and transferred to a nitrocellulose membrane. The membrane was blocked with 5% milk and blotted with rabbit anti-␤ 2 m polyclonal antibody, as described (2) .
Frequency of the FHH Mutation. We amplified exon 1 of ␤ 2 m from cellular genomic DNA of 100 control individuals of north European descent and from serum genomic DNA of the two affected siblings of British ancestry by using the forward primer 5Ј-TGAAGTCCTAGAATGAACGCCC-3Ј and reverse primer 5Ј-CGCCCTGAACTTTGTCCCG-3Ј, in accordance with the conditions described above. The 488-bp PCR-amplified fragment was purified by using a Montage PCR centrifugal filter (Millipore) and eluted in 20 l of water. DNA was digested at 37°C overnight with 10 units of restriction enzyme HinP1I (New England Biolabs) that recognizes five GCGC sequences within the 488-bp PCR-amplified fragment, one of which is the site of the FHH mutation. The digested DNA was resolved on a 2% ethidium bromide-stained agarose gel and visualized on a UV transilluminator.
